Ngā hua rapu kaituhi

1

Multifocal Motor Neuropathy: Update on Clinical Characteristics, Pathophysiological Concepts and Therapeutic Options mā Sven G. Meuth, Christoph Kleinschnitz

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies mā Nico Melzer, Sven G. Meuth

I whakaputaina 2013

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

CD8<sup>+</sup>T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability mā Nico Melzer, Sven G. Meuth, Heinz Wiendl

I whakaputaina 2009

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system mā Nico Melzer, Sven G. Meuth, Heinz Wiendl

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Blood-brain barrier modeling: challenges and perspectives mā Tobias Ruck, Stefan Bittner, SvenG Meuth

I whakaputaina 2015

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Cytokine signaling in multiple sclerosis: Lost in translation mā Kerstin Göbel, Tobias Ruck, Sven G. Meuth

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
7

Evaluating base and retrieval augmented LLMs with document or online support for evidence based neurology mā Lars Masanneck, Sven G. Meuth, Marc Pawlitzki

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond mā Tobias Ruck, Stefan Bittner, Heinz Wiendl, Sven G. Meuth

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
9

From the Background to the Spotlight: TASK Channels in Pathological Conditions mā Stefan Bittner, Thomas Budde, Heinz Wiendl, Sven G. Meuth

I whakaputaina 2010

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
10

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment mā Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis mā Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
12

Myelin Oligodendrocyte Glycoprotein (MOG<sub>35-55</sub>) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice mā Stefan Bittner, Ali Maisam Afzali, Heinz Wiendl, Sven G. Meuth

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration mā Anna M. Speicher, Heinz Wiendl, Sven G. Meuth, Matthias Pawlowski

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management mā Stefan Bittner, Tobias Ruck, Heinz Wiendl, Oliver Grauer, Sven G. Meuth

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
15

Skeletal muscle as potential central link between sarcopenia and immune senescence mā Christopher Nelke, Rainer Dziewas, Jens Minnerup, Sven G. Meuth, Tobias Ruck

I whakaputaina 2019

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
16

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders mā Tobias Brummer, Tobias Ruck, Sven G. Meuth, Frauke Zipp, Stefan Bittner

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Isolation of Primary Murine Brain Microvascular Endothelial Cells mā Tobias Ruck, Stefan Bittner, Lisa Epping, Alexander M. Herrmann, Sven G. Meuth

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Cellular senescence in neuroinflammatory disease: new therapies for old cells? mā Christopher Nelke, Christina B. Schroeter, Marc Pawlitzki, Sven G. Meuth, Tobias Ruck

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

The three-year evolution of Germany’s Digital Therapeutics reimbursement program and its path forward mā Linea Schmidt, Marc Pawlitzki, Bernhard Y. Renard, Sven G. Meuth, Lars Masanneck

I whakaputaina 2024

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling mā Jay S. Coggan, Stefan Bittner, Klaus M. Stiefel, Sven G. Meuth, Steven A. Prescott

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Sven G. Meuth

Multifocal Motor Neuropathy: Update on Clinical Characteristics, Pathophysiological Concepts and Therapeutic Options mā Sven G. Meuth, Christoph Kleinschnitz

Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies mā Nico Melzer, Sven G. Meuth

CD8<sup>+</sup>T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability mā Nico Melzer, Sven G. Meuth, Heinz Wiendl

Paraneoplastic and non-paraneoplastic autoimmunity to neurons in the central nervous system mā Nico Melzer, Sven G. Meuth, Heinz Wiendl

Blood-brain barrier modeling: challenges and perspectives mā Tobias Ruck, Stefan Bittner, SvenG Meuth

Cytokine signaling in multiple sclerosis: Lost in translation mā Kerstin Göbel, Tobias Ruck, Sven G. Meuth

Evaluating base and retrieval augmented LLMs with document or online support for evidence based neurology mā Lars Masanneck, Sven G. Meuth, Marc Pawlitzki

Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond mā Tobias Ruck, Stefan Bittner, Heinz Wiendl, Sven G. Meuth

From the Background to the Spotlight: TASK Channels in Pathological Conditions mā Stefan Bittner, Thomas Budde, Heinz Wiendl, Sven G. Meuth

Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment mā Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto

The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis mā Eduardo Duarte-Silva, Sven G. Meuth, Christina Alves Peixoto

Myelin Oligodendrocyte Glycoprotein (MOG&lt;sub&gt;35-55&lt;/sub&gt;) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice mā Stefan Bittner, Ali Maisam Afzali, Heinz Wiendl, Sven G. Meuth

Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration mā Anna M. Speicher, Heinz Wiendl, Sven G. Meuth, Matthias Pawlowski

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management mā Stefan Bittner, Tobias Ruck, Heinz Wiendl, Oliver Grauer, Sven G. Meuth

Skeletal muscle as potential central link between sarcopenia and immune senescence mā Christopher Nelke, Rainer Dziewas, Jens Minnerup, Sven G. Meuth, Tobias Ruck

Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disorders mā Tobias Brummer, Tobias Ruck, Sven G. Meuth, Frauke Zipp, Stefan Bittner

Isolation of Primary Murine Brain Microvascular Endothelial Cells mā Tobias Ruck, Stefan Bittner, Lisa Epping, Alexander M. Herrmann, Sven G. Meuth

Cellular senescence in neuroinflammatory disease: new therapies for old cells? mā Christopher Nelke, Christina B. Schroeter, Marc Pawlitzki, Sven G. Meuth, Tobias Ruck

The three-year evolution of Germany’s Digital Therapeutics reimbursement program and its path forward mā Linea Schmidt, Marc Pawlitzki, Bernhard Y. Renard, Sven G. Meuth, Lars Masanneck

Physiological Dynamics in Demyelinating Diseases: Unraveling Complex Relationships through Computer Modeling mā Jay S. Coggan, Stefan Bittner, Klaus M. Stiefel, Sven G. Meuth, Steven A. Prescott

Ngā utauta rapu:

Ngā marau whai pānga

Myelin Oligodendrocyte Glycoprotein (MOG<sub>35-55</sub>) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice mā Stefan Bittner, Ali Maisam Afzali, Heinz Wiendl, Sven G. Meuth